About this site
Healthspanner is a reading library for healthy adults — what actually works for healthspan, what doesn't, and how strong the evidence is. Distilled from peer-reviewed literature, checked against its sources, and written in plain language.
Why this site exists
Search any longevity question and the first results are usually some mix of supplement-store blogs, influencer videos summarising one viral paper, glossy magazine pieces citing nothing, and forum threads arguing past each other. The signal exists — in randomized trials, Mendelian-randomization analyses, large prospective cohorts, and the occasional good meta-analysis — but it sits buried under marketing, anecdote, and isolated findings dressed up as breakthroughs. Most popular write-ups stop at one or two pet studies and skip everything that complicates the headline.
This site is an attempt to surface the actual evidence base. Each topic was reviewed across a large body of peer-reviewed literature, distilled into something a healthy midlife adult can read in a sitting — with the evidence strength and the load-bearing citations attached, and the limits of the data named out loud rather than smoothed over.
How the site is organised
The site is layered, so you can stop at whatever depth answers your question:
- Home and the long list — the short answers, plus one aggregated list of what to actually do.
- Pillar pages — one per area (sleep, exercise, nutrition, supplements, clinical care and so on): what the evidence supports there, with links down into the articles.
- Articles — about 90, each on one topic (sauna, creatine, fasting, VO₂ max…), short and in plain language: what the evidence shows, what to do, and where the evidence runs out.
- Detail pages— more than 200 short pages on a single substance, test, trial or concept, listed under “Details” in the sidebar. They hold the study-level detail that would otherwise clutter an article, and any article that needs one links to it.
Most articles also have a technical version, linked from the article: the longer, denser original with the full study-by-study discussion. It is kept up to date — a factual correction made to an article goes into its technical version too.
The source corpus
The site started from about two dozen long-form research reviews, each synthesising a large slice of the literature for one domain (sleep, VO₂ max, protein and mTOR, sauna, alcohol, geroprotectors, and so on). Since then each article has been researched again on its own against the current literature: randomized controlled trials, Mendelian-randomization analyses, prospective cohorts, meta-analyses, and the occasional landmark mechanistic paper. The breadth is the point — a single trial rarely settles a longevity question, and the picture only emerges once the surrounding literature is read alongside it.
Wherever a claim is meaningful enough to anchor a recommendation, its source is named in the running text — by trial, journal, and year (e.g. “PREDIMED, NEJM 2018”) — and linked to the paper or trial registry where one exists.
The method: AI-assisted, checked in stages
The research and writing are done by AI models working through a fixed, multi-step process that the site's editor directs and signs off on. Each article goes through it one at a time:
- Critical review.The article is checked against its own sources and its sibling pages: overstated or stale effect sizes, claims the cited paper doesn't support, numbers that contradict another page.
- Deep literature review.The claims are researched against the outside literature, with particular attention to recent work. Separate “skeptic” passes then try to refute each proposed correction before it is accepted.
- Applying the corrections. Accepted changes are made in the article and in every other page that repeats the same claim, and a reviewer that did not make the edits checks them.
- Plain-language rewrite. The article is rewritten short and readable, study-level detail moves to detail pages, and the long original is kept as the technical version. This step changes how things are said, not what is said.
- Independent fact-check. A fresh checker compares the rewritten article and its detail pages against the original and the stored sources, looking for new numbers, shifted claims, and dropped harms or caveats.
- Citation verification. Scripts check every PubMed link: that the ID resolves, and that the paper it points to is the one the link text names.
AI is good at breadth and recall; it is less reliable at calibration, and it can produce plausible citations that don't exist or don't say what is claimed. The stages above exist because of exactly those failures — earlier sweeps of this site found wrong claims and mismatched citations, which were then fixed everywhere they appeared. The checks have limits worth naming: the checkers are themselves AI, the automated citation check covers only PubMed links (papers linked elsewhere rely on the review stages), and no physician or other outside expert has reviewed the pages.
How evidence strength is shown
Rather than stamping a grade on each section, the articles say how strong the evidence is in the sentence that makes the claim: “randomized trials show…”, “in observational studies…”, “the evidence is thin”, “so far only in mice”. The wording follows the usual hierarchy of evidence:
- Strongest — multiple large randomized trials, or meta-analyses of them, with hard endpoints (death, heart attack, fracture, a dementia diagnosis).
- Good but limited — consistent trials that measure markers (blood pressure, LDL cholesterol, a scan) rather than outcomes, run in narrow populations, or disagree with each other.
- Weak or preliminary — small or single trials, mostly animal data, or only observational associations, which can show a link but not that one thing causes the other.
- Harm signals — a documented risk at common doses is stated plainly, next to the benefit it qualifies.
The technical versions predate this style and still carry explicit Strong / Moderate / Weak / Caution labels on their sections.
Editorial principles
- Plain language at the top, depth deeper down. Teasers and pillar pages are written for an average reader; acronyms and trial names appear once the context is set.
- Quantify when possible.“30% reduction in CVD events” beats “significantly reduces.”
- Acknowledge uncertainty. Observational data, Mendelian-randomization caveats, and industry funding are called out rather than hidden.
- Don't moralize. Especially around alcohol, weight, or behavioral choices. The evidence is presented; readers decide.
- No supplement, brand, or program promotion. Generic recommendations only.
What this site is not
- Not medical advice. Nothing here is a prescription. Discuss any meaningful change with a clinician who knows your history.
- Not exhaustive. The deep-dive articles are distillations. If a claim matters to you, follow the citation through to the primary source.
- Not static. The evidence base moves — the alcohol J-curve has largely collapsed since 2019, the dementia-risk attributable fraction keeps climbing as new modifiers are identified. Pages are updated when meaningful new evidence lands.
Corrections and feedback
If you find a factual error, a missing citation, or a study that should overturn a current claim, it is worth raising. A correction that holds up is applied to every page that repeats the claim — the article, its technical version, its detail pages and the summary pages above them — not just the one where it was spotted. Corrections are made quickly; structural changes take longer.